Invention Grant
![Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins](/docs/US/2020-06-30/US10696670B2/abs.jpg.600x600.jpg)
- Patent Title: Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
-
Application No.: US16298762Application Date: 2019-03-11
-
Publication No.: US10696670B2Publication Date: 2020-06-30
- Inventor: Abdelmalik Slassi , Peter Dove
- Applicant: Trillium Therapeutics Inc.
- Applicant Address: CA Mississauga
- Assignee: Trillium Therapeutics Inc.
- Current Assignee: Trillium Therapeutics Inc.
- Current Assignee Address: CA Mississauga
- Agency: Bereskin & Parr LLP/S.E.N.C.R.L., S.R.L.
- Agent Patricia Folkins
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K31/4745 ; A61K45/06 ; A61K31/496 ; A61K31/5377 ; A61K51/04
![Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins](/abs-image/US/2020/06/30/US10696670B2/abs.jpg.150x150.jpg)
Abstract:
A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins.
Public/Granted literature
- US20190202825A1 FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS Public/Granted day:2019-07-04
Information query
